Renaud Louis

Renaud Louis

Université de Liège

H-index: 74

Europe-Belgium

About Renaud Louis

Renaud Louis, With an exceptional h-index of 74 and a recent h-index of 54 (since 2020), a distinguished researcher at Université de Liège, specializes in the field of Respiratory Medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Ciliary beating remains stable 9 hours after brushing, but is modified by storage temperature

Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

Tezepelumab (Tezspire®): new biological treatment of severe asthma

MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study

Rehabilitation After Severe Coronavirus Disease: What Are the Long Term Outcomes?

Evidence for 2 clusters among patients with noneosinophilic asthma

When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease …

Renaud Louis Information

University

Université de Liège

Position

CHU Liege

Citations(all)

18358

Citations(since 2020)

9337

Cited By

12109

hIndex(all)

74

hIndex(since 2020)

54

i10Index(all)

238

i10Index(since 2020)

174

Email

University Profile Page

Université de Liège

Renaud Louis Skills & Research Interests

Respiratory Medicine

Top articles of Renaud Louis

Title

Journal

Author(s)

Publication Date

Ciliary beating remains stable 9 hours after brushing, but is modified by storage temperature

Revue des Maladies Respiratoires

N Bricmont

R Bonhiver

L Benchimol

L Bruno

JF Papon

...

2024/3/1

Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

The Journal of Allergy and Clinical Immunology: In Practice

Rafael José Vieira

Lucas Leemann

Andrew Briggs

Ana Margarida Pereira

Marine Savouré

...

2024/3/30

Tezepelumab (Tezspire®): new biological treatment of severe asthma

Revue Medicale de Liege

Florence Schleich

Mare Sabbe

Catherine Moermans

Renaud Louis

2024/1/1

MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

The Journal of Allergy and Clinical Immunology: In Practice

Jean Bousquet

Bernardo Sousa-Pinto

Josep M Anto

Anna Bedbrook

Joao A Fonseca

...

2024/3/21

Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study

Pediatric Allergy and Immunology

Bernardo Sousa‐Pinto

Arunas Valiulis

Erik Melén

Gerard H Koppelman

Nikolaos G Papadopoulos

...

2024/2

Rehabilitation After Severe Coronavirus Disease: What Are the Long Term Outcomes?

V Heinen

M Delvenne

P Sauveur

M Henket

RE Louis

2024/5

Evidence for 2 clusters among patients with noneosinophilic asthma

Annals of Allergy, Asthma & Immunology

Halehsadat Nekoee Zahraei

Florence Schleich

Gilles Louis

Sara Gerday

Mare Sabbe

...

2024/3/16

When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease …

Journal of Medical Case Reports

M Sabbe

F Schleich

P Janssens

R Louis

2024/1/31

Dupilumab: a new treatment for severe T2 high asthma

Revue Medicale de Liege

Renaud Louis

Mare Sabbe

Nicolas Bougard

Anne-Noëlle Frix

Florence Schleich

2024/4/1

Randomized clinical trial: Impact of Bactecal® on asthma control and inflammation

Revue des Maladies Respiratoires

C Moermans

S Graff

L Medard

H Nekoee

A-F Donneau

...

2024/3/1

Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium

Sara Tomassetti

Luca Ciani

Valentina Luzzi

Leonardo Gori

Marco Trigiani

...

2024

Concept of remission in severe asthma

Revue Medicale de Liege

Jeanne Vervier

Françoise Guissard

Monique Henket

Doriane Calmes

Claudine Wirth

...

2024/4/1

Ciliary dyskinesia might be reduced in cystic fibrosis patients diagnosed by newborn screening

Revue des Maladies Respiratoires

R Bonhiver

N Bricmont

M Pirotte

M-A Wuidart

R Louis

...

2024/3/1

Le médicament du mois. Tézépélumab (Tezspire®): nouveau traitement biologique de l’asthme sévère.

Revue Médicale de Liège

FLorence Schleich

Mare SABBE

Catherine Moermans

Renaud Louis

2024

The GOLD (Global Initiative for Chronic Obstructive Lung Disease) 2023: a substantial revision

Revue Medicale de Liege

Louise Ansiaux

Olivier Bonhomme

Vincent Heinen

Florence Schleich

Renaud Louis

2024/4/1

Asthma in the digital world

Jean Bousquet

Bernardo Sousa-Pinto

Francesca Puggioni

Aram Anto

Fabio Balli

...

2023/1/1

Nouveautés dans le diagnostic et la stratification du risque de l’hypertension pulmonaire.

Revue Médicale de Liège

Quentin Maloir

Hélène PETITJEAN

Gilles Parzibut

Thierry Weber

Cédric DAVIDSEN

...

2023

La pathologie pulmonaire associée à la polyarthrite rhumatoïde.

Revue Médicale de Liège

Anna DENIS

Anne-Noëlle Frix

Delphine NGUYEN DANG

Olivier Malaise

Céline DEFOURNY

...

2023

Cutoff values of MASK-air patient-reported outcome measures

The Journal of Allergy and Clinical Immunology: In Practice

Bernardo Sousa-Pinto

Ana Sá-Sousa

Rafael José Vieira

Rita Amaral

Ana Margarida Pereira

...

2023/4/1

Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis

Frontiers in Medicine

Julien Guiot

Monique Henket

Marie Ernst

Laurence Seidel

Marie Winandy

...

2023/3/9

See List of Professors in Renaud Louis University(Université de Liège)

Renaud Louis FAQs

What is Renaud Louis's h-index at Université de Liège?

The h-index of Renaud Louis has been 54 since 2020 and 74 in total.

What are Renaud Louis's top articles?

The articles with the titles of

Ciliary beating remains stable 9 hours after brushing, but is modified by storage temperature

Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

Tezepelumab (Tezspire®): new biological treatment of severe asthma

MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study

Rehabilitation After Severe Coronavirus Disease: What Are the Long Term Outcomes?

Evidence for 2 clusters among patients with noneosinophilic asthma

When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease …

...

are the top articles of Renaud Louis at Université de Liège.

What are Renaud Louis's research interests?

The research interests of Renaud Louis are: Respiratory Medicine

What is Renaud Louis's total number of citations?

Renaud Louis has 18,358 citations in total.